Concomitant methotrexate has little effect on clinical outcomes of abatacept in rheumatoid arthritis: a propensity

Nobunori Takahashi1, Toshihisa Kojima2, Daihei Kida3

  • 1Department of Orthopedic Surgery and Rheumatology, Nagoya University Hospital, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan. nobunori@med.nagoya-u.ac.jp.

Abstract

Insights

In rheumatoid arthritis, abatacept showed similar clinical outcomes whether or not patients also took methotrexate (MTX). This suggests abatacept is a viable treatment option, even for those who cannot take MTX.

Area of Science:

  • Rheumatology
  • Immunology
  • Clinical Pharmacology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease.
  • Abatacept is a biologic therapy used for RA treatment.
  • The role of concomitant methotrexate (MTX) with abatacept in RA management requires further clarification in real-world settings.

Purpose of the Study:

  • To compare the clinical outcomes of abatacept in rheumatoid arthritis patients with and without concomitant methotrexate (MTX) treatment.
  • To evaluate the efficacy and safety of abatacept in routine clinical practice.

Main Methods:

  • Retrospective cohort study utilizing a multicentre registry.
  • Propensity score matching was employed to create comparable groups of patients with (MTX(+)) and without (MTX(-)) concomitant MTX.
  • Clinical outcomes were assessed over a 52-week period.

Main Results:

  • Baseline characteristics were comparable between the MTX(-) and MTX(+) groups.
  • No significant differences were observed in drug retention rates, disease activity scores (DAS28-CRP), low disease activity rates, clinical remission rates, or EULAR response rates at 52 weeks.
  • Specific outcomes included drug retention (79.1%/80.5%), mean DAS28-CRP change (-1.35/-1.54), and good EULAR response (36.6%/41.1%) at 52 weeks.

Conclusions:

  • Concomitant methotrexate does not appear to significantly affect the clinical outcomes of abatacept treatment in RA patients with similar baseline characteristics.
  • Abatacept is a suitable treatment option in daily practice, particularly for RA patients with contraindications to MTX.
  • This study provides real-world evidence on abatacept efficacy, minimizing physician bias through registry data analysis.

Related Concept Videos

Sign Test for Matched Pairs01:17

Sign Test for Matched Pairs

The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
392
Introduction to z Scores01:06

Introduction to z Scores

A z score (or standardized value) is measured in units of the standard deviation. It tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one.
z scores...
11.0K
Introduction to z Scores01:05

Introduction to z Scores

A z score (or standardized value) is measured in units of the standard deviation. It indicates how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one.
z scores...
1.3K
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
18.4K
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.4K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
106.8K